Cancer Rop Co. Ltd. (KQ:180400) — Stock Price

₩2385.00 KRW
▲ 0.63% today

Cancer Rop Co. Ltd. (KQ:180400) is currently trading at ₩2385.00 KRW, up 0.63% today. Over the past 52 weeks, shares have ranged between ₩1983.00 and ₩2760.00. This page tracks Cancer Rop Co. Ltd.'s live share price on the KQ exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Cancer Rop Co. Ltd. stock valuation.

Cancer Rop Co. Ltd. (180400) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Cancer Rop Co. Ltd.'s daily closing share price and trading volume on the KQ exchange over the past year, giving a clear view of recent price momentum and liquidity.

Cancer Rop Co. Ltd. Income Statement — Revenue, Profit & Earnings by Year

Cancer Rop Co. Ltd.'s annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222018
Total Revenue ₩29.36 Billion ₩33.95 Billion ₩41.24 Billion ₩32.18 Billion ₩7.51 Billion
Cost of Revenue ₩26.04 Billion ₩28.81 Billion ₩33.67 Billion ₩22.12 Billion ₩6.38 Billion
Gross Profit ₩3.32 Billion ₩5.14 Billion ₩7.58 Billion ₩10.06 Billion ₩1.13 Billion
Research & Development ₩8.63 Billion ₩10.28 Billion ₩3.33 Billion ₩791.53 Million ₩757.47 Million
SG&A ₩11.29 Billion ₩7.25 Billion ₩6.49 Billion ₩1.78 Billion ₩5.20 Billion
Total Operating Expenses ₩53.68 Billion ₩55.55 Billion ₩56.69 Billion ₩29.55 Billion ₩12.60 Billion
Operating Income ₩-24.32 Billion ₩-21.60 Billion ₩-15.45 Billion ₩2.63 Billion ₩-5.09 Billion
EBITDA — — — — —
EBIT — — — — ₩-5.09 Billion
Interest Expense ₩2.80 Billion ₩4.80 Billion ₩5.44 Billion ₩1.44 Billion ₩0.00
Income Before Tax ₩-31.99 Billion ₩-55.93 Billion ₩-30.37 Billion ₩-2.85 Billion ₩-6.28 Billion
Income Tax Expense — — — — ₩-917.21 Million
Net Income ₩-29.04 Billion ₩-47.03 Billion ₩-27.48 Billion ₩-779.65 Million ₩-5.37 Billion

Cancer Rop Co. Ltd. Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Cancer Rop Co. Ltd.'s financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222018
Total Assets ₩154.87 Billion ₩72.36 Billion ₩99.94 Billion ₩85.95 Billion ₩67.54 Billion
Total Current Assets ₩114.97 Billion ₩29.56 Billion ₩28.79 Billion ₩38.66 Billion ₩11.66 Billion
Cash & Equivalents — — — — —
Short-term Investments ₩1.58 Billion ₩1.60 Billion ₩5.04 Billion ₩1.56 Billion ₩950.92 Million
Net Receivables ₩3.44 Billion ₩8.06 Billion ₩6.94 Billion ₩8.95 Billion ₩1.00 Billion
Inventory ₩2.50 Billion ₩7.39 Billion ₩7.32 Billion ₩2.44 Billion ₩1.57 Billion
Property, Plant & Equipment — — — — ₩9.00 Billion
Goodwill ₩360.12 Million ₩360.12 Million ₩9.68 Billion ₩9.07 Billion —
Total Liabilities ₩59.11 Billion ₩56.00 Billion ₩71.14 Billion ₩51.60 Billion ₩32.64 Billion
Total Current Liabilities ₩21.76 Billion ₩18.53 Billion ₩57.51 Billion ₩31.66 Billion ₩1.65 Billion
Long-term Debt ₩32.75 Billion ₩31.74 Billion ₩5.16 Billion ₩15.27 Billion ₩30.91 Billion
Net Debt — ₩32.46 Billion ₩31.41 Billion ₩9.30 Billion —
Total Stockholder Equity ₩93.95 Billion ₩13.97 Billion ₩21.17 Billion ₩33.97 Billion ₩34.91 Billion
Retained Earnings ₩-150.93 Billion ₩-120.69 Billion ₩-73.63 Billion ₩-45.60 Billion ₩-9.59 Billion

Cancer Rop Co. Ltd. Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Cancer Rop Co. Ltd. generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222018
Operating Cash Flow ₩-18.85 Billion ₩-20.03 Billion ₩-12.06 Billion ₩865.55 Million ₩-4.94 Billion
Capital Expenditures ₩1.41 Billion ₩833.90 Million ₩2.18 Billion ₩1.74 Billion ₩4.17 Billion
Free Cash Flow ₩-20.27 Billion ₩-20.86 Billion ₩-14.25 Billion ₩-873.01 Million —
Investing Cash Flow — — — — ₩-34.59 Billion
Financing Cash Flow — — — — ₩10.55 Billion
Dividends Paid — — — — —
Stock-Based Compensation ₩-17.29 Million ₩-30.74 Million ₩3.31 Billion ₩1.02 Billion —
Depreciation ₩1.72 Billion ₩1.78 Billion ₩2.42 Billion ₩1.37 Billion ₩515.12 Million
Change in Cash ₩93.82 Billion ₩2.09 Billion ₩-17.76 Billion ₩23.57 Billion ₩-28.99 Billion

Cancer Rop Co. Ltd. Earnings History — EPS Actual vs. Analyst Estimates

Track Cancer Rop Co. Ltd.'s quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Earnings history is not currently available for Cancer Rop Co. Ltd..